Park Medi World Ltd Surges to 52-Week High on Strategic Acquisitions and Strong Financial Performance

By PNN | Updated: February 12, 2026 13:55 IST2026-02-12T19:21:06+5:302026-02-12T13:55:03+5:30

Mumbai (Maharashtra) [India], February 12: Park Medi World Ltd experienced a significant surge in its stock value on Thursday, ...

Park Medi World Ltd Surges to 52-Week High on Strategic Acquisitions and Strong Financial Performance | Park Medi World Ltd Surges to 52-Week High on Strategic Acquisitions and Strong Financial Performance

Park Medi World Ltd Surges to 52-Week High on Strategic Acquisitions and Strong Financial Performance

Mumbai (Maharashtra) [India], February 12: Park Medi World Ltd experienced a significant surge in its stock value on Thursday, with shares climbing 5.5 per cent to reach a new 52-week high of Rs 179.55. This impressive gain, up from its previous closing of Rs 170.25, was accompanied by a notable increase in trading volume on the BSE, exceeding 1.06 times the usual activity. The upward momentum reflects investor confidence fueled by the company’s aggressive expansion strategy and robust financial results.

The recent 100 per cent acquisition of KP Institute of Medical Sciences (KPIMS) in Agra for approximately Rs 245 crore marks a pivotal moment for Park Medi World Ltd, significantly broadening its regional presence. This all-cash transaction, managed through its subsidiary Blue Heavens Health Care Pvt Ltd, introduces a 360-bed, NABH-accredited facility, reinforcing the group’s strategic cluster-based expansion model in Uttar Pradesh. Complementing the recent integration of Krishna Super Speciality Hospital in Bhatinda and Febris Multi-Speciality Hospital in Narela, these acquisitions substantially enhance the company’s capacity in high-growth urban markets. Park Medi World Ltd is strategically positioned to achieve its ambitious target of 5,260 beds by March 2028, all while upholding its commitment to delivering affordable healthcare to underserved communities.

Financially, the company continues to demonstrate strong growth. In the third quarter of fiscal year 2026, net sales rose by 18 per cent to Rs 410 crore, with net profit climbing 16 per cent to Rs 52.80 crore, compared to the same period last year. The first nine months of FY26 have also shown remarkable progress, with net sales increasing by 17 per cent to Rs 1,218.90 crore and net profit surging by an impressive 43 per cent to Rs 196.80 crore.

Disclaimer: This article is for informational purposes only and does not constitute financial advice.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in app